Finecure Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 12.71 Cr
as on 11-12-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 85.69 Cr
as on 11-12-2024
- Satisfied Charges ₹ 8.58 Cr
as on 11-12-2024
- Revenue 8.25%
(FY 2024)
- Profit -30.02%
(FY 2024)
- Ebitda -14.35%
(FY 2024)
- Net Worth 5.99%
(FY 2024)
- Total Assets 10.15%
(FY 2024)
About Finecure Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 12.71 Cr.
The company currently has active open charges totaling ₹85.69 Cr. The company has closed loans amounting to ₹8.58 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Finecure Pharmaceuticals Limited India are Sonamben Zatkiya as COMPANY SECRETARY and Ashish Sanghvi as Cfo. Mukesh Agarwal, Vivek Rajgarhia, Vishal Rajgarhia, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2005PLC045724
- Company No.
045724
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Finecure Pharmaceuticals Limited offer?
Finecure Pharmaceuticals Limited offers a wide range of products and services, including Common Disease Medicines, Steroid, Sexual Wellness Products, Contraceptives, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs.
Who are the key members and board of directors at Finecure Pharmaceuticals?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vikash Rajgarhia ![]() | Managing Director | 18-Mar-2005 | Current |
Sonamben Zatkiya | Company Secretary | 28-Dec-2017 | Current |
Ashish Sanghvi | CFO | 28-Dec-2017 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mukesh Agarwal ![]() | Director | 21-Dec-2017 | Current |
Vivek Rajgarhia ![]() | Whole-Time Director | 18-Mar-2005 | Current |
Vishal Rajgarhia ![]() | Whole-Time Director | 18-Mar-2005 | Current |
Anshu Agrawal ![]() | Director | 21-Dec-2017 | Current |
Financial Performance of Finecure Pharmaceuticals.
Finecure Pharmaceuticals Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 8.25% increase. The company also saw a substantial fall in profitability, with a 30.02% decrease in profit. The company's net worth moved up by a moderate rise of 5.99%.
![Revenue Growth Graph](/Images/financial/revenue-growth.webp)
![Profit Loss Graph](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Finecure Pharmaceuticals?
In 2024, Finecure Pharmaceuticals had a promoter holding of 96.85% and a public holding of 3.15%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
![Shareholding Indiacator](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Related Corporates (Common Directorship)
- Finebiotics Pharma LimitedActive 20 years 4 months
Mukesh Agarwal and Vivek Rajgarhia are mutual person
- Finecure FoundationActive 3 years 10 months
Vivek Rajgarhia, Vishal Rajgarhia and 1 more are mutual person
- Global Medisciences LimitedActive 21 years 6 months
Vivek Rajgarhia, Vishal Rajgarhia and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 06 Sep 2023 | ₹5.90 Cr | Open |
Sidbi Creation Date: 24 Mar 2023 | ₹1.89 Cr | Open |
State Bank Of India Creation Date: 12 Jan 2023 | ₹18.00 Cr | Open |
How Many Employees Work at Finecure Pharmaceuticals?
Finecure Pharmaceuticals has a workforce of 405 employees as of Dec 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
![Employee Graph](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Valuation-Graph](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Finecure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finecure Pharmaceuticals's trajectory.
Rating
![Rating-Graph](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert-Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.